Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
77
self-reported 51–200 band
Founded
2010
16 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
7
Post IPO equity · Aug 2025 · US$ 132.4M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
CLARITY PHARMACEUTICALS LTD
ABN36143005341
Legal entities
Show as table · Clarity Pharmaceuticals: 1 registry entity
| CLARITY PHARMACEUTICALS LTD | ABN 36143005341 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Clarity is a clinical stage radiopharmaceutical company developing next-generation products to address the growing need for the use of radiopharmaceuticals in oncology.
Clarity is a global leader in Targeted Copper Theranostics (TCT), developed with its proprietary SAR Technology platform. TCT are the next-generation disruptive platform in radiopharmaceuticals that employ the “perfect pairing” of copper-64 and copper-67 for diagnosis and therapy. TCT deliver a compelling combination of high accuracy and high precision in the treatment of a range of cancers, as well as providing supply and logistical advantages over current theranostics. TCT provide a highly efficacious, scalable, and cost-effective way to expand radiopharmaceuticals into the global oncology market.
Clarity has a diverse range of products in clinical trials which address both large indications (prostate cancer and breast cancer) as well as small and orphan indications (neuroendocrine tumours (NETs) and neuroblastoma) of cancer. Our ultimate goal is to improve treatment outcomes for children and adults with cancer.
Specialties
All 7 specialties
- Antibody and peptide imaging
- Pharmaceutical imaging
- Companion diagnostics
- Drug development
- Radiopharmaceuticals
- Nuclear medicine
- Targeted therapy
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUNational Innovation Centre; 4 Cornwallis Street; Sydney, NSW 2015Primary
Grid intelligence Members
Funding
Last round · 28 August 2025US$ 132.4MPost IPO equity
Rounds7
Round typePost IPO equity · secondary transaction
Amount (USD)132,400,000
Stage rank6
Investors named0
Since last round4 mo
Funding
Show as table · 7 funding rounds
| Rounds | 7 |
|---|---|
| Axis | 2010 to 2026 |
| Post IPO equity · 28 Aug 2025 | US$ 132.4M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Clarity Pharmaceuticals?
One New South Wales entity on the ABR: CLARITY PHARMACEUTICALS LTD (ABN 36 143 005 341), high confidence.
How many people work at Clarity Pharmaceuticals?
77 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Clarity Pharmaceuticals have offices?
One address on record, Australia only. Primary: National Innovation Centre, 4 Cornwallis Street, Sydney, NSW 2015.
Has Clarity Pharmaceuticals raised funding?
Seven rounds. Latest 28 August 2025: post IPO equity, US$132,400,000.
What does Clarity Pharmaceuticals list as its specialties?
Seven tags on the brand's own list, among them nuclear medicine.
Which companies are listed alongside Clarity Pharmaceuticals?
20 profiles list Clarity Pharmaceuticals as a peer — 93rd percentile in Biotechnology Research. It lists ten peers of its own. Telix Pharmaceuticals Limited and Radiopharm Theranostics list it back.